PBH
Prestige Consumer Healthcare·NYSE
--
--(--)
--
--(--)
PBH fundamentals
Prestige Consumer Healthcare (PBH) Revenue Breakdown: Q3 2026 Business & Regional Performance
Prestige Consumer Healthcare (PBH) reported total revenue of 283.44M USD in Q3 2026, with its core business segment Analgesics contributing 9.89%. Regionally, North American remained the largest market, accounting for 83.15% of total revenue. Explore Prestige Consumer Healthcare's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Prestige Consumer Healthcare (PBH) reported total revenue of 283.44M USD in Q3 2026, with its core business segment Analgesics contributing 9.89%. Regionally, North American remained the largest market, accounting for 83.15% of total revenue. Explore Prestige Consumer Healthcare's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Prestige Consumer Healthcare next quarter?What guidance did Prestige Consumer Healthcare's management provide for the next earnings period?What were the key takeaways from Prestige Consumer Healthcare’s earnings call?What is the revenue and EPS growth rate for Prestige Consumer Healthcare year over year?What were the key takeaways from Prestige Consumer Healthcare's earnings call?What factors drove the changes in Prestige Consumer Healthcare's revenue and profit?What does Prestige Consumer Healthcare do and what are its main business segments?What is Prestige Consumer Healthcare's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
